Severe hemolysis associated with use of the impella LP 2.5 mechanical assist device

Catheterization and Cardiovascular Interventions

Volumn 80, Issue 5, 2012, Pages 840-844

  Sibbald, Matthew ^a   Džavík, Vladimír ^a,b  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

hemolysis; impella; percutaneous coronary intervention complications; percutaneous implantable left ventricular assist device

Indexed keywords

ACETYLSALICYLIC ACID; ADRENALIN; ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CALCIUM; CLOPIDOGREL; CREATINE KINASE; FIBRINOGEN; HAPTOGLOBIN; HEMOGLOBIN; LACTATE DEHYDROGENASE; LACTIC ACID; PHOSPHATE; POTASSIUM; TROPONIN I;

AGED; ANGIOCARDIOGRAPHY; ARTICLE; ASPIRATION PNEUMONIA; BRAIN HEMORRHAGE; CARDIOVERSION; CASE REPORT; CENTRAL VENOUS PRESSURE; CORONARY ARTERY CALCIFICATION; CORONARY ARTERY OBSTRUCTION; CORONARY STENT; DEVICE REMOVAL; DEVICE THERAPY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HEART ASSIST DEVICE; HEART ATRIUM FIBRILLATION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART OUTPUT; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; HYPOTENSION; INTERNATIONAL NORMALIZED RATIO; INTRAAORTIC BALLOON PUMP; INTRAVASCULAR HEMOLYSIS; ISCHEMIC HEART DISEASE; KIDNEY FAILURE; LIVER DYSFUNCTION; PARTIAL THROMBOPLASTIN TIME; PERCUTANEOUS CORONARY INTERVENTION; RECURRENT DISEASE; THROMBOCYTE COUNT; VASCULAR RESISTANCE;

AGED; BIOLOGICAL MARKERS; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; DEVICE REMOVAL; FEMALE; HEART-ASSIST DEVICES; HEMODYNAMICS; HEMOLYSIS; HUMANS; PERCUTANEOUS CORONARY INTERVENTION; PROSTHESIS DESIGN; SHOCK, CARDIOGENIC; VENTRICULAR FUNCTION, LEFT;

EID: 84867899828     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.24280     Document Type: Article

References (20)

1. Chowdhary S, Ivanov J, Mackie K, Seidelin PH, Dzavik V,. The toronto score for in-hospital mortality after percutaneous coronary interventions. Am Heart J 2009; 157: 156-163.
2. Moscucci M, Kline-Rogers E, Share D, O'Donnell M, Maxwell-Eward A, Meengs WL, Kraft P, DeFranco AC, Chambers JL, Patel K, McGinnity JG, Eagle KA,. Simple bedside additive tool for prediction of in-hospital mortality after percutaneous coronary interventions. Circulation 2001; 104: 263-268.
3. Singh M, Lennon RJ, Holmes DR Jr., Bell MR, Rihal CS,. Correlates of procedural complications and a simple integer risk score for percutaneous coronary intervention. J Am Coll Cardiol 2002; 40: 387-393.
4. Wu C, Hannan EL, Walford G, Ambrose JA, Holmes DR Jr., King SB III, Clark LT, Katz S, Sharma S, Jones RH,. A risk score to predict in-hospital mortality for percutaneous coronary interventions. J Am Coll Cardiol 2006; 47: 654-660.
5. Briguori C, Sarais C, Pagnotta P, Airoldi F, Liistro F, Sgura F, Spanos V, Carlino M, Montorfano M, Di Mario C, Colombo A,. Elective versus provisional intra-aortic balloon pumping in high-risk percutaneous transluminal coronary angioplasty. Am Heart J 2003; 145: 700-707.
6. Mishra S, Chu WW, Torguson R, Wolfram R, Deible R, Suddath WO, Pichard AD, Satler LF, Kent KM, Waksman R,. Role of prophylactic intra-aortic balloon pump in high-risk patients undergoing percutaneous coronary intervention. Am J Cardiol 2006; 98: 608-612.
7. Perera D, Stables R, Thomas M, Booth J, Pitt M, Blackman D, de Belder A, Redwood S,. Elective intra-aortic balloon counterpulsation during high-risk percutaneous coronary intervention: A randomized controlled trial. JAMA 2010; 304: 867-874.
8. Siess T, Nix C, Menzler F,. From a lab type to a product: A retrospective view on impella's assist technology. Artif Organs 2001; 25: 414-421.
9. Dixon SR, Henriques JP, Mauri L, Sjauw K, Civitello A, Kar B, Loyalka P, Resnic FS, Teirstein P, Makkar R, Palacios IF, Collins M, Moses J, Benali K, O'Neill WW,. A prospective feasibility trial investigating the use of the impella 2.5 system in patients undergoing high-risk percutaneous coronary intervention (the protect i trial): Initial u.S. Experience. JACC Cardiovasc Interv 2009; 2: 91-96.
10. Goldstein DJ,. Worldwide experience with the micromed debakey ventricular assist device as a bridge to transplantation. Circulation 2003; 108 Suppl 1: II272-II277.
11. Slaughter MS,. Hematologic effects of continuous flow left ventricular assist devices. J Cardiovasc Transl Res 2010; 3: 618-624.
12. Siegenthaler MP, Brehm K, Strecker T, Hanke T, Notzold A, Olschewski M, Weyand M, Sievers H, Beyersdorf F,. The impella recover microaxial left ventricular assist device reduces mortality for postcardiotomy failure: A three-center experience. J Thorac Cardiovasc Surg 2004; 127: 812-822.
13. Mueller XM, Boone Y, Augstburger M, Horisberger J, von Segesser LK,. Bi-ventricular axial micropump: Impact on blood cell integrity. Swiss Surg. 2001; 7: 213-217.
14. Minden HH, Lehmann H, Meyhofer J, Butter C,. Transradial unprotected left main coronary stenting supported by percutaneous impella recover lp 2.5 assist device. Clin Res Cardiol 2006; 95: 301-306.
15. Meyns B, Autschbach R, Boning A, Konertz W, Matschke K, Schondube F, Wiebe K, Fischer E,. Coronary artery bypass grafting supported with intracardiac microaxial pumps versus normothermic cardiopulmonary bypass: A prospective randomized trial. Eur J Cardiothorac Surg 2002; 22: 112-117.
16. Jurmann MJ, Siniawski H, Erb M, Drews T, Hetzer R,. Initial experience with miniature axial flow ventricular assist devices for postcardiotomy heart failure. Ann Thorac Surg 2004; 77: 1642-1647.
17. Meyns B, Dens J, Sergeant P, Herijgers P, Daenen W, Flameng W,. Initial experiences with the impella device in patients with cardiogenic shock-Impella support for cardiogenic shock. Thorac Cardiovasc Surg 2003; 51: 312-317.
18. Valgimigli M, Steendijk P, Serruys PW, Vranckx P, Boomsma F, Onderwater E, Vaina S, Ligthart JM, McFadden E, van der Ent M, de Jaegere P, Sianos G,. Use of impella recover(r) lp 2.5 left ventricular assist device during high-risk percutaneous coronary interventions; clinical, haemodynamic and biochemical findings. EuroIntervention 2006; 2: 91-100.
19. Seyfarth M, Sibbing D, Bauer I, Frohlich G, Bott-Flugel L, Byrne R, Dirschinger J, Kastrati A, Schomig A,. A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction. J Am Coll Cardiol 2008; 52: 1584-1588.
20. Apel J, Paul R, Klaus S, Siess T, Reul H,. Assessment of hemolysis related quantities in a microaxial blood pump by computational fluid dynamics. Artif Organs 2001; 25: 341-347.